The stock of Nuwellis Inc (NUWE) has gone down by -13.96% for the week, with a -74.02% drop in the past month and a -77.09% drop in the past quarter. The volatility ratio for the week is 8.17%, and the volatility levels for the past 30 days are 21.15% for NUWE. The simple moving average for the past 20 days is -30.29% for NUWE’s stock, with a -80.77% simple moving average for the past 200 days.
Is It Worth Investing in Nuwellis Inc (NASDAQ: NUWE) Right Now?
Company’s 36-month beta value is -0.04.Analysts have differing opinions on the stock, with 0 analysts rating it as a “buy,” 1 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for NUWE is 3.04M, and currently, short sellers hold a 82.77% ratio of that floaft. The average trading volume of NUWE on July 03, 2025 was 10.05M shares.
NUWE) stock’s latest price update
The stock price of Nuwellis Inc (NASDAQ: NUWE) has dropped by -5.10% compared to previous close of $0.23. Despite this, the company has seen a fall of -13.96% in its stock price over the last five trading days. globenewswire.com reported 2025-07-02 that WHO WHAT WHERE WHEN HOW John Erb Appointed as Chief Executive Officer (no longer serving in an interim capacity) Nuwellis Headquarters Effective June 27, 2025 Appointment confirmed by the Board of Directors following his interim leadership MINNEAPOLIS, July 02, 2025 (GLOBE NEWSWIRE) — Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company dedicated to advancing solutions in fluid management, today announced the appointment of John Erb as its Chief Executive Officer. Erb, who has served as interim CEO since February 2025, will continue to lead the company with a focus on strategic clarity, operational discipline, and sustainable growth.
Analysts’ Opinion of NUWE
Many brokerage firms have already submitted their reports for NUWE stocks, with ROTH MKM repeating the rating for NUWE by listing it as a “Buy.” The predicted price for NUWE in the upcoming period, according to ROTH MKM is $17 based on the research report published on July 29, 2024 of the previous year 2024.
NUWE Trading at -68.26% from the 50-Day Moving Average
After a stumble in the market that brought NUWE to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -96.24% of loss for the given period.
Stock Fundamentals for NUWE
Current profitability levels for the company are sitting at:
- -1.06 for the present operating margin
- 0.63 for the gross margin
The net margin for Nuwellis Inc stands at -1.12. The total capital return value is set at -2.18. Equity return is now at value -440.77, with -144.12 for asset returns.
Based on Nuwellis Inc (NUWE), the company’s capital structure generated 0.12 points at debt to capital in total, while cash flow to debt ratio is standing at -18.83. The debt to equity ratio resting at 0.14. The interest coverage ratio of the stock is -1.66.
Currently, EBITDA for the company is -5.24 million with net debt to EBITDA at 0.26. When we switch over and look at the enterprise to sales, we see a ratio of -0.12. The receivables turnover for the company is 5.71for trailing twelve months and the total asset turnover is 1.25. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.23.
Conclusion
In a nutshell, Nuwellis Inc (NUWE) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
